Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate
- PMID: 1591724
Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate
Abstract
In vitro exposure of the TR170 ovarian carcinoma cell line to six intermittent 24-h treatments with a 90% inhibitory concentration of cisplatin (CDDP) (0.15 micrograms/ml; 0.5 microM) resulted in a 2-fold stably resistant subline designated TR170/CP+ (B.T. Hill et al., Int. J. Cancer, 39: 219-225, 1987). Resistance to CDDP in these CP+ cells has now been associated with reduced uptake of 195mCDDP (2-fold; P less than 0.01) and decreased removal of specific Pt-DNA adducts, quantitated immunochemically, indicative of an apparent increased tolerance of CDDP-induced DNA damage. Specifically these resistant cells appeared deficient in removal of the major cis-Pt-(NH3)2d(pGpG) adduct and the difunctional cis-Pt(NH3)2d(GMP)2 lesion, showed less efficiency in removing cis-Pt(NH3)2d(pApG) adducts, but proved as proficient as the parental cell line in removing DNA-DNA interstrand cross-links. Activities of DNA polymerase-alpha and -beta were comparable in both lines, and no significant alterations in glutathione metabolism were identified. Response to acute X-irradiation was not modified in these TR170/CP+ cells, but they showed marked (10-fold) cross-resistance to 5-fluorouracil and, unusually, proved collaterally sensitive (12-fold) to methotrexate. Resistance to 5-fluorouracil was associated with significantly increased thymidylate synthase activity (P less than 0.01), but this was not reflected in altered gene expression, while increased sensitivity to methotrexate was accompanied by increased drug uptake but by unaltered activity and expression of dihydrofolate reductase. These results indicate that exposure to CDDP can result in numerous alterations, both intracellularly and at the cellular membrane, reflected in significant changes in the tumor cells' responses to the cytotoxic effects of a range of antitumor drugs. The clinical relevance of these observations remains to be established.
Similar articles
-
Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.Carcinogenesis. 1992 Jul;13(7):1209-15. doi: 10.1093/carcin/13.7.1209. Carcinogenesis. 1992. PMID: 1638688
-
Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.Cancer Res. 1991 Sep 1;51(17):4557-64. Cancer Res. 1991. PMID: 1873800
-
Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.Cancer Res. 1992 Apr 1;52(7):1710-6. Cancer Res. 1992. PMID: 1312897
-
The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin.Crit Rev Toxicol. 2010 Apr;40(4):347-59. doi: 10.3109/10408441003601836. Crit Rev Toxicol. 2010. PMID: 20163198 Review.
-
Resistance to cisplatin and analogues: mechanisms and potential clinical implications.Cancer Chemother Pharmacol. 1988;22(4):325-32. doi: 10.1007/BF00254240. Cancer Chemother Pharmacol. 1988. PMID: 3048763 Review.
Cited by
-
Systems biology of cisplatin resistance: past, present and future.Cell Death Dis. 2014 May 29;5(5):e1257. doi: 10.1038/cddis.2013.428. Cell Death Dis. 2014. PMID: 24874729 Free PMC article. Review.
-
In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.Br J Cancer. 1993 Aug;68(2):240-50. doi: 10.1038/bjc.1993.322. Br J Cancer. 1993. PMID: 8347478 Free PMC article.
-
Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.Jpn J Cancer Res. 1995 Jan;86(1):88-94. doi: 10.1111/j.1349-7006.1995.tb02992.x. Jpn J Cancer Res. 1995. PMID: 7737915 Free PMC article.
-
Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.Invest New Drugs. 1994;12(3):169-82. doi: 10.1007/BF00873957. Invest New Drugs. 1994. PMID: 7896535
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous